Skip to main content
Neuland Laboratories Limited. logo

Neuland Laboratories Limited. — Investor Relations & Filings

Ticker · NEULANDLAB ISIN · INE794A01010 LEI · 335800AVHZURTYQ17N08 BSE.NS Manufacturing
Open in API
Filings indexed 947 across all filing types
Latest filing 2020-07-31 Regulatory Filings
Country IN India
Listing BSE.NS NEULANDLAB

About Neuland Laboratories Limited.

https://www.neulandlabs.com

Neuland Laboratories Limited specializes in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and provides comprehensive Custom Manufacturing Solutions (CMS). The company focuses on complex chemistry and high-quality standards, operating state-of-the-art manufacturing facilities that comply with international regulatory requirements, including those of the USFDA and EDQM. Its product portfolio spans diverse therapeutic areas such as cardiovascular, central nervous system, anti-infectives, and antiasthmatics. Neuland supports pharmaceutical companies globally through the entire lifecycle of a drug, from early-stage clinical development to commercial-scale production. By leveraging advanced technical expertise and a robust quality management system, the organization delivers reliable chemical synthesis and process optimization services to both innovator and generic drug manufacturers.

Recent filings

Filing Released Lang Actions
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 90% confidence The document is an announcement of an upcoming earnings call for Neuland Laboratories Limited regarding its Q1FY21 results. It provides details about the date, time, dial-in numbers, and background information about the company. There are no actual financial results or detailed financial statements included in the text. The document is short (2127 characters) and serves to inform about the earnings call event rather than presenting the earnings results themselves. Therefore, it is best classified as a Call Transcript (CT) announcement or related to earnings call, but since it is only an announcement of the call and not the transcript, it fits best under Regulatory Filings (RNS) as a general regulatory announcement about the earnings call event.
2020-07-31 English
Board Meeting — Financial Results
Regulatory Filings Classification · 95% confidence The document is a notice from the company to stock exchanges informing about an upcoming Board Meeting scheduled for August 4, 2020, to consider and take on record the unaudited financial results for the quarter ended June 30, 2020. It also mentions the trading window closure and reopening in compliance with insider trading regulations. The document does not contain any financial data or results itself, nor does it include a full report or detailed financial statements. It is an announcement of a Board Meeting and related procedural information. Therefore, it fits best under the category of Regulatory Filings (RNS) as a general regulatory announcement rather than a financial report or other specific filing type.
2020-07-16 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings Classification · 95% confidence The document is a certificate issued under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended June 30, 2020. It is a compliance certificate from the Registrar and Share Transfer Agent certifying details of securities dematerialized/rematerialized during the period. The document is addressed to stock exchanges and is a regulatory compliance filing rather than a financial report or announcement of financial results. It does not contain financial statements or management discussion, nor is it an announcement of voting results or capital changes. It is primarily a regulatory compliance certificate. Therefore, the most appropriate classification is Regulatory Filings (RNS). The document length is about 4913 characters, which is consistent with a certificate rather than a full report.
2020-07-14 English
Shareholders meeting
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a detailed communication regarding the outcome of the 36th Annual General Meeting (AGM) of Neuland Laboratories Limited held on July 10, 2020. It includes a summary of proceedings, voting results, and the report of the scrutinizer. The content covers the conduct of the AGM via video conferencing, the resolutions passed including adoption of audited financial statements, dividend confirmation, director appointments, and remuneration ratification. The document is not the full annual report or financial statements themselves but rather a comprehensive report on the AGM proceedings and voting outcomes. This fits the definition of 'Declaration of Voting Results & Voting Rights Announcements (DVA)' as it officially reports the results from shareholder votes at the AGM. The document length and detail confirm it is not a brief announcement or a simple notice but a full disclosure of AGM voting results and related information.
2020-07-10 English
Copy of Newspaper Publication
Regulatory Filings Classification · 95% confidence The document is a notice addressed to stock exchanges regarding the transfer of equity shares to the Investor Education and Protection Fund (IEPF) as per the Companies Act and related rules. It includes a reference to a published notice in newspapers and requests the exchanges to take the information on record. The document is short (1290 characters) and does not contain any financial statements, management discussion, or detailed report content. It is an announcement of a regulatory action related to share transfers, not a financial report or detailed filing. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2020-07-01 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges regarding the closure of the trading window pursuant to SEBI regulations ahead of the announcement of unaudited financial results for the quarter ended June 30, 2020. It does not contain any financial data or results itself, but rather informs about the trading restrictions and the upcoming board meeting date for results consideration. The document length is short (1414 characters) and serves as an announcement or notification rather than a report. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2020-06-30 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.